Literature DB >> 26700440

B Cells, Antibodies, and More.

William Hoffman1, Fadi G Lakkis2, Geetha Chalasani3.   

Abstract

B cells play a central role in the immunopathogenesis of glomerulonephritides and transplant rejection. B cells secrete antibodies that contribute to tissue injury via multiple mechanisms. In addition, B cells contribute to disease pathogenesis in autoimmunity and alloimmunity by presenting antigens as well as providing costimulation and cytokines to T cells. B cells also play an immunomodulatory role in regulating the immune response by secreting cytokines that inhibit disease onset and/or progression. B cell-targeted approaches for treating immune diseases of the kidney and other organs have gained significant momentum. However, much remains to be understood about B-cell biology in order to determine the timing, duration, and context of optimal therapeutic response to B cell-targeted approaches. In this review, we discuss the multifaceted roles of B cells as enhancers and regulators of immunity with relevance to kidney disease and transplantation.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Antibodies; B regulatory cells; B-Lymphocytes; T-Lymphocytes; autoimmunity; cytokines; glomerulonephritis; graft rejection; immune system diseases; plasma cells

Mesh:

Substances:

Year:  2015        PMID: 26700440      PMCID: PMC4702236          DOI: 10.2215/CJN.09430915

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  189 in total

1.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

2.  Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.

Authors:  Eduardo F Mysler; Alberto J Spindler; Renato Guzman; Marc Bijl; David Jayne; Richard A Furie; Frédéric A Houssiau; Jorn Drappa; David Close; Romeo Maciuca; Kajal Rao; Saba Shahdad; Paul Brunetta
Journal:  Arthritis Rheum       Date:  2013-09

3.  B cells help alloreactive T cells differentiate into memory T cells.

Authors:  Y-H Ng; M H Oberbarnscheidt; H C K Chandramoorthy; R Hoffman; G Chalasani
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

Review 4.  Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.

Authors:  Stamatis-Nick C Liossis; Konstantinos Melissaropoulos
Journal:  Expert Opin Pharmacother       Date:  2014-03-04       Impact factor: 3.889

5.  Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.

Authors:  Vladimir M Liarski; Natalya Kaverina; Anthony Chang; Daniel Brandt; Denisse Yanez; Lauren Talasnik; Gianluca Carlesso; Ronald Herbst; Tammy O Utset; Christine Labno; Yahui Peng; Yulei Jiang; Maryellen L Giger; Marcus R Clark
Journal:  Sci Transl Med       Date:  2014-04-02       Impact factor: 17.956

6.  A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.

Authors:  Rick Kapur; Iwan Kustiawan; Anne Vestrheim; Carolien A M Koeleman; Remco Visser; Helga K Einarsdottir; Leendert Porcelijn; Dave Jackson; Belinda Kumpel; André M Deelder; Dennis Blank; Björn Skogen; Mette Kjaer Killie; Terje E Michaelsen; Masja de Haas; Theo Rispens; C Ellen van der Schoot; Manfred Wuhrer; Gestur Vidarsson
Journal:  Blood       Date:  2013-11-15       Impact factor: 22.113

7.  B cell biomarkers of rituximab responses in systemic lupus erythematosus.

Authors:  Edward M Vital; Shouvik Dass; Maya H Buch; Karen Henshaw; Colin T Pease; Michael F Martin; Frederique Ponchel; Andrew C Rawstron; Paul Emery
Journal:  Arthritis Rheum       Date:  2011-10

8.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

9.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; David Savitsky; Jerry Liao; Kathryn Calame
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

Review 10.  Pax5: the guardian of B cell identity and function.

Authors:  César Cobaleda; Alexandra Schebesta; Alessio Delogu; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

View more
  101 in total

Review 1.  The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.

Authors:  Laura Annaratone; Eliano Cascardi; Elena Vissio; Ivana Sarotto; Ewa Chmielik; Anna Sapino; Enrico Berrino; Caterina Marchiò
Journal:  Pathobiology       Date:  2020-04-23       Impact factor: 4.342

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 3.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

Review 4.  Regulation of B cell fate, survival, and function by mitochondria and autophagy.

Authors:  Hector Sandoval; Srikanth Kodali; Jin Wang
Journal:  Mitochondrion       Date:  2017-11-23       Impact factor: 4.160

5.  B cell phenotype in pediatric idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Rita Carsetti; Simona Cascioli; Jessica Serafinelli; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2018-09-28       Impact factor: 3.714

6.  CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.

Authors:  Yong Zhang; Xiuying Zhang; Yan Xia; Xiao Jia; Hao Li; Yanyan Zhang; Zhen Shao; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng; Yonghai Liu; Guiyun Cui; Ruiguo Dong; Xiaoyu Huang; Tingyan Yu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

7.  A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Authors:  Richard A Lafayette; Pietro A Canetta; Brad H Rovin; Gerald B Appel; Jan Novak; Karl A Nath; Sanjeev Sethi; James A Tumlin; Kshama Mehta; Marie Hogan; Stephen Erickson; Bruce A Julian; Nelson Leung; Felicity T Enders; Rhubell Brown; Barbora Knoppova; Stacy Hall; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

8.  The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice.

Authors:  Marc-Werner Dobenecker; Jonas Marcello; Annette Becker; Eugene Rudensky; Natarajan V Bhanu; Thomas Carrol; Benjamin A Garcia; Rabinder Prinjha; Vyacheslav Yurchenko; Alexander Tarakhovsky
Journal:  FEBS Lett       Date:  2020-08-29       Impact factor: 4.124

Review 9.  Immune pathogenesis of heparin-induced thrombocytopenia.

Authors:  Sanjay Khandelwal; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2016-07-28       Impact factor: 5.249

10.  OMIP-068: High-Dimensional Characterization of Global and Antigen-Specific B Cells in Chronic Infection.

Authors:  Katherine Cascino; Mario Roederer; Thomas Liechti
Journal:  Cytometry A       Date:  2020-08-28       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.